EKF Diagnostics (LON:EKF) Trading Down 7% - Here's Why

Key Points

• EKF Diagnostics' stock price decreased by 7% to GBX 26 ($0.35) on Friday, amid a trading volume that was 404% higher than its average session.
• The company reported a net margin of 9.37% and a return on equity of 7.03% in its latest earnings results.
• EKF Diagnostics specializes in Point-of-Care analysers and manufactures enzymes for various diagnostic, food, and industrial applications, with a global footprint in over 120 countries.

EKF Diagnostics Holdings plc (LON:EKF - Get Free Report)'s stock price traded down 7% during trading on Friday . The stock traded as low as GBX 23.60 ($0.31) and last traded at GBX 26 ($0.35). 2,281,890 shares were traded during trading, an increase of 404% from the average session volume of 453,091 shares. The stock had previously closed at GBX 27.95 ($0.37).

EKF Diagnostics Trading Down 7.0%

The stock has a market capitalization of £116.76 million, a price-to-earnings ratio of 19.26 and a beta of 0.57. The company's 50 day moving average is GBX 29.26 and its 200 day moving average is GBX 26.56. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.77 and a current ratio of 4.60.

EKF Diagnostics (LON:EKF - Get Free Report) last released its earnings results on Tuesday, September 16th. The company reported GBX 0.43 EPS for the quarter. EKF Diagnostics had a net margin of 9.37% and a return on equity of 7.03%. On average, research analysts forecast that EKF Diagnostics Holdings plc will post 2.2987842 EPS for the current fiscal year.

EKF Diagnostics Company Profile

EKF is an AIM-listed global diagnostics business focussed on: ● Point-of-Care analysers in the key areas of Hematology and Diabetes ● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications. EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.